Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea

M. Lazzarino, E. Morra, E. Brusamolino, E. P. Alessandrino, E. Orlandi, G. Pagnucco, C. Castagnola, P. Bernasconi, S. Merante, M. Bonfichi, G. Castelli, A. Canevari, C. Bernasconi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea'. Together they form a unique fingerprint.

Medicine & Life Sciences